Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Immunomodulatory Effects of Nanocurcumin on Th17 Cell Responses in Mild and Severe Covid-19 Patients Publisher Pubmed



Tahmasebi S1 ; Elesawi MA2 ; Mahmoud ZH3 ; Timoshin A4 ; Valizadeh H5 ; Roshangar L6 ; Varshoch M7 ; Vaez A7 ; Aslani S8 ; Navashenaq JG9 ; Aghebatimaleki L10 ; Ahmadi M6
Authors

Source: Journal of Cellular Physiology Published:2021


Abstract

In novel coronavirus disease 2019 (COVID-19), the increased frequency and overactivation of T helper (Th) 17 cells and subsequent production of large amounts of proinflammatory cytokines result in hyperinflammation and disease progression. The current study aimed to investigate the therapeutic effects of nanocurcumin on the frequency and responses of Th17 cells in mild and severe COVID-19 patients. In this study, 40 severe COVID-19 intensive care unit-admitted patients and 40 patients in mild condition were included. The frequency of Th17 cells, the messenger RNA expression of Th17 cell-related factors (RAR-related orphan receptor γt, interleukin [IL]-17, IL-21, IL-23, and granulocyte-macrophage colony-stimulating factor), and the serum levels of cytokines were measured in both nanocurcumin and placebo-treated groups before and after treatment. A significant decrease in the number of Th17 cells, downregulation of Th17 cell-related factors, and decreased levels of Th17 cell-related cytokines were found in mild and severe COVID-19 patients treated by nanocurcumin compared to the placebo group. Moreover, the abovementioned parameters were significantly decreased in the nanocurcumin-treated group after treatment versus before treatment. Curcumin could reduce the frequency of Th17 cells and their related inflammatory factors in both mild and severe COVID-19 patients. Hence, it could be considered as a potential modulatory compound in improving the patient's inflammatory condition. © 2020 Wiley Periodicals LLC
Other Related Docs
9. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
11. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
16. Immunologic Profile of Severe Covid-19 Patients in Alborz Province, Iran, Jundishapur Journal of Microbiology (2023)
20. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)